"
Team:Heidelberg/Project
From 2013.igem.org
| Line 110: | Line 110: | ||
<p style="font-size:14px; text-align:justify"> | <p style="font-size:14px; text-align:justify"> | ||
</p> | </p> | ||
| - | + | <img src="https://2013.igem.org/File:Heidelberg_Del_Cluster.png" width="200"> </img> Schematic representation of DelH cluster and structure of delftibactin. | |
| + | Delftibactin is a NRP produced by a hybrid NRPS/ polyketide synthase (PKS) system. In their recent publication, Johnston ''et al.'' <bib id="pmid23377039"/> predicted that the enzymes responsible for producing delftibactin are encoded on a single gene cluster, hereafter referred to as Del cluster. It comprises 59 kbp encoding for 21 genes. DelE, DelF, DelG and DelH constitute the hybrid NRPS/ PKS system producing delftibactin, with DelE, DelG and DelH being NRPS and DelF the PKS. The remaining enzymes involved in the Delftibactin synthesis pathway are required for NPRS/ PKS maturation or post-synthesis modification of Delftibactin. The predicted activities of the assumed proteins are: :</p> | ||
<ol style="font-size:14px"> | <ol style="font-size:14px"> | ||
<li>DelA: MbtH-like protein, most likely required for efficient delftibactin synthesis[Pmid21826462]</li> | <li>DelA: MbtH-like protein, most likely required for efficient delftibactin synthesis[Pmid21826462]</li> | ||
| Line 135: | Line 136: | ||
<li>DelH</li> | <li>DelH</li> | ||
<li>DelA-P - The rest of the genes of the Del-cluster</li> | <li>DelA-P - The rest of the genes of the Del-cluster</li> | ||
| - | Basic Strategy will be described in the following paragraphs. For further detailed experiments you can visit our LabJournal[Link to labjournal]. | + | Basic Strategy will be described in the following paragraphs. For further detailed experiments you can visit our LabJournal [Link to labjournal]. |
</ol> | </ol> | ||
<ol> | <ol> | ||
| Line 142: | Line 143: | ||
As the gene encoding DelH alone has a size of 18 kb we decided to clone and introduce this huge gene on a separate plasmid. The first restriction enzyme strategy was problematic because of DelH amplification and the low yield in the ligation. A new GibsonAssembly-strategy was performed and DelH amplified in smaller pieces. It seemed to appear the same problem of as in the pIK1 that E.coli is selecting out the mutated DelH-constructs or is activly mutating it for toxic reasons. A plasmid was designed with the same low copy promotor as in the pIK8 and a low copy RBS [BBa_]. Another shot was a plasmid without promotor so that E.coli has no need to express and mutate DelH. Finally DelH is going to be inserted in DH10ß and BL21 via electroporation.</li> | As the gene encoding DelH alone has a size of 18 kb we decided to clone and introduce this huge gene on a separate plasmid. The first restriction enzyme strategy was problematic because of DelH amplification and the low yield in the ligation. A new GibsonAssembly-strategy was performed and DelH amplified in smaller pieces. It seemed to appear the same problem of as in the pIK1 that E.coli is selecting out the mutated DelH-constructs or is activly mutating it for toxic reasons. A plasmid was designed with the same low copy promotor as in the pIK8 and a low copy RBS [BBa_]. Another shot was a plasmid without promotor so that E.coli has no need to express and mutate DelH. Finally DelH is going to be inserted in DH10ß and BL21 via electroporation.</li> | ||
<li> | <li> | ||
| - | DelA-P (the rest of the genes of the Del-cluster) [File:Del cluster.gb] was amplified with different primer combinations out of D.acidovorans, and a plasmid was created containing these genes on the pSB4K5 Backbone with lacI promotor and without mRFP. The | + | DelA-P (the rest of the genes of the Del-cluster) [File:Del cluster.gb] was amplified with different primer combinations out of D.acidovorans, and a plasmid was created containing these genes on the pSB4K5 Backbone with lacI promotor and without mRFP. The was transformed into DH10ß and BL21(DE3) via electroporation.</li> |
</ol> | </ol> | ||
<p style="font-size:14px"> | <p style="font-size:14px"> | ||
Revision as of 13:59, 4 October 2013
Project
Notebook
Human Practice
Delftibactin. Recycling Gold from Electronic Waste.
Highlights
- Transfer of the whole delftibactin NRPS pathway from D. acidovorans into E. coli
- Novel approach for transfering a whole NRPS pathway more than 50 kb in size from one bacterial species into another
- Optimization of the Gibson Cloning Strategy for the creation of large plasmids (over 30 kb in size) with high GC content
- Precipitation of pure gold from electronic waste using delftibactin
Abstract
Efficient recycling of gold from electronic waste using recombinant delftibactin
Undoubtedly, gold is one of the most precious materials on earth. Besides its common use in art and jewelry, gold is also an essential component of our modern computers and cell-phones. Due to the fast turn-over of today’s high-tech equipment, millions of tons of electronic waste accumulate each year containing tons of this valuable metal. The main approach nowadays to recycle gold from electronic waste is by electrolysis. Unfortunately, this is a highly inefficient and expensive procedure, preventing most of the gold from being recovered.
Earlier this year, a publication in Nature Chemical Biology reported the existence of a non-ribosomal peptide – delftibactin - which has the astonishing property to specifically precipitate elemental gold from gold-ion containing solutions. Naturally, delftibactin is produced by Delftia acidovorans, an extremophile bacterium, which secretes delftibactin to complexate and dispose of toxic gold ions present in its environment. Although the exact delftibactin production pathway is not known, bioinformatic predictions claim a non-ribosomal peptide synthesis pathway encoded on a large, 59 kb gene cluster (the del-cluster) to be responsible for delftibactin production.
In this subproject we want to demonstrate that the natural secondary metabolite delftibactin can be efficiently produced in E. coli and used for the recycling of gold from electronic waste. To this end, we developed a cloning strategy based on an optimized Gibson Assembly protocol, enabling the cloning of large, GC-rich genomic regions onto regular low-copy plasmids. We thereby engineered three different plasmids (about 70 kb in total size) enabling the expression of the predicted del-cluster from regular E. coli promoters along with the methylmalonyl-CoA pathway providing the basic delftibactin building blocks and a NRPS activating PPTase, Sfp from Bacillus subtilis.
We want to show that these large constructs can be potentially inserted and expressed by E. coli with the promising perspective that delftibactin could readily be used as an efficient way of gold recycling from electronic waste.
Introduction
The quest for a magical substance to generate gold from inferior metals stirred the imagination of generations. However, this substance, the Philosopher’s Stone, stands for more than just the desire to produce gold. In the old days, the fabled Philosopher’s Stone also represented wisdom, rejuvenation and health. Nowadays, gold is still of great importance for us as it is needed for most of our electronic devices.
In 2007, more than two tons of gold were discarded hidden in electronic waste in Germany. Most of the precious element end up on waste disposal sites as only a minor fraction of 28 % of the gold is recycled
Besides economical usage of the resource gold, one way to reduce global demands for gold is elevation of gold recovery
This extremophile has the incredible ability to withstand toxic amounts of gold ions in contaminated soil
Delftibactin is no ordinary peptide but a non-ribosomal peptide (NRP)
Schematic representation of DelH cluster and structure of delftibactin.
Delftibactin is a NRP produced by a hybrid NRPS/ polyketide synthase (PKS) system. In their recent publication, Johnston ''et al.'' - DelA: MbtH-like protein, most likely required for efficient delftibactin synthesis[Pmid21826462]
- DelB: thioesterase
- DelC: 4'-phosphopanteinyl transferase: required for maturation of ACP/PCP subunits
- DelD: taurine dioxygenase
- DelL: Ornithine N-monooxygenase
- DelP: N5-hydroxyornithine formyltransferase
We aimed to introduce the large Del cluster into the commonly used, easy-to-culture model organism E. coli to produce Delftibactin. This target bacterium already possesses many components needed for the functionality of non-ribosomal-peptide synthetases. Nevertheless, we introduce nearly the entire Del cluster intoE. coli except for DelC (native PPTase). This function is covered by the sfp phosphopanteinyl transferaseintroduced from Bacillus subtilis. As DelF is a PKS, it requires methylmalonyl-CoA as substrate, which is not produced by E. coli. Therefore, the MMCoA synthesis pathway from B. subtilus which is able to activate a wide variety of PKSs including those from Saccharomyces cerevisiae
The resulting engineered E. coli could be used as host for the delftibactin synthesis pathway, possibly also eliminating the need to introduce DelC. As promoters of the Del cluster were only predicted
Facing these challenges, we decided to approach the project straight forward by cultivation of D. acidovorans and the isolation of native Delftibactin to reproduce the findings of ohnston et al.
Experiments
Our aim is to express delftibactin in E.coli. This will be achieved by introducing three different plasmids which contain parts of the delftibactin-cluster [File:Del cluster.gb] ,a Methylmalonyl-CoA pathway, a Pptase which replaces the DelC-function and a permeability device for the export of the desired NRP.
- Methylmalonyl-CoA, ppTase & permeability device
- DelH
- DelA-P - The rest of the genes of the Del-cluster Basic Strategy will be described in the following paragraphs. For further detailed experiments you can visit our LabJournal [Link to labjournal].
- Our first aim was to achieve a genomic integration of the genes that encode for components of the Methylmalonyl-CoA pathway into E.coli. The presence of this pathway is required for the production of NRPs. Because the genomic integration turned out to be more challenging then expected a new strategy was developed. Therefore, two plasmids were created (pIK2) containing MethylmalonylCoA amplified from Streptomyces coeliolor and a ppTase amplified from Bacillus subtilis in the Biobrick Backbone pSB3C5 and the permeability device (BBa_I746200) for the outer membrane of E.coli was inserted in another plasmid (pIK1). Team Cambridge revealed in 2007 that Bba_I746200 is toxic. It was itherefore inserted into pIK2 between the two terminators driven by a weak promoter (BBa_J23114) and a weak RBS (Bba_B0030), yielding pIK8 with a total size of 9467 bp, which was inserted in DH10ß and BL21DE3 via electroporation.
- As the gene encoding DelH alone has a size of 18 kb we decided to clone and introduce this huge gene on a separate plasmid. The first restriction enzyme strategy was problematic because of DelH amplification and the low yield in the ligation. A new GibsonAssembly-strategy was performed and DelH amplified in smaller pieces. It seemed to appear the same problem of as in the pIK1 that E.coli is selecting out the mutated DelH-constructs or is activly mutating it for toxic reasons. A plasmid was designed with the same low copy promotor as in the pIK8 and a low copy RBS [BBa_]. Another shot was a plasmid without promotor so that E.coli has no need to express and mutate DelH. Finally DelH is going to be inserted in DH10ß and BL21 via electroporation.
- DelA-P (the rest of the genes of the Del-cluster) [File:Del cluster.gb] was amplified with different primer combinations out of D.acidovorans, and a plasmid was created containing these genes on the pSB4K5 Backbone with lacI promotor and without mRFP. The was transformed into DH10ß and BL21(DE3) via electroporation.
All three plasmid were then electroporated together into BL21 and are able to export delftibactin which reduces soluble gold-ions out of the solution when present in the media.
Results
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.s dyes), pharmaceutical development (such as antibiotics) and recycling (such as chelators).
- blabla
- balbla
